269 related articles for article (PubMed ID: 19147349)
1. Synthesis and pharmacological evaluation of aminopyrimidine series of 5-HT1A partial agonists.
Dounay AB; Barta NS; Bikker JA; Borosky SA; Campbell BM; Crawford T; Denny L; Evans LM; Gray DL; Lee P; Lenoir EA; Xu W
Bioorg Med Chem Lett; 2009 Feb; 19(4):1159-63. PubMed ID: 19147349
[TBL] [Abstract][Full Text] [Related]
2. New arylpiperazine 5-HT(1A) receptor ligands containing the pyrimido[2,1-f]purine fragment: synthesis, in vitro, and in vivo pharmacological evaluation.
Jurczyk S; Kołaczkowski M; Maryniak E; Zajdel P; Pawłowski M; Tatarczyńska E; Kłodzińska A; Chojnacka-Wójcik E; Bojarski AJ; Charakchieva-Minol S; Duszyńska B; Nowak G; Maciag D
J Med Chem; 2004 May; 47(10):2659-66. PubMed ID: 15115407
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of new serotonin 5-HT7 receptor ligands. Determinants of 5-HT7/5-HT1A receptor selectivity.
Medina RA; Sallander J; Benhamú B; Porras E; Campillo M; Pardo L; López-Rodríguez ML
J Med Chem; 2009 Apr; 52(8):2384-92. PubMed ID: 19326916
[TBL] [Abstract][Full Text] [Related]
4. Novel, flexible, and conformationally defined analogs of gepirone: synthesis and 5-HT1A, 5-HT2A, and D2 receptor activity.
Paluchowska MH; Bugno R; Bojarski AJ; Charakchieva-Minol S; Duszyńska B; Tatarczyńska E; Kłodzińska A; Stachowicz K; Chojnacka-Wójcik E
Bioorg Med Chem; 2005 Feb; 13(4):1195-200. PubMed ID: 15670928
[TBL] [Abstract][Full Text] [Related]
5. Designing selective, high affinity ligands of 5-HT1D receptor by covalent dimerization of 5-HT1F ligands derived from 4-fluoro-N-[3-(1-methyl-4-piperidinyl)-1H-indol-5-yl]benzamide.
Choi SK; Green D; Ho A; Klein U; Marquess D; Taylor R; Turner SD
J Med Chem; 2008 Jun; 51(12):3609-16. PubMed ID: 18507369
[TBL] [Abstract][Full Text] [Related]
6. Indolebutylamines as selective 5-HT(1A) agonists.
Heinrich T; Böttcher H; Bartoszyk GD; Greiner HE; Seyfried CA; Van Amsterdam C
J Med Chem; 2004 Sep; 47(19):4677-83. PubMed ID: 15341483
[TBL] [Abstract][Full Text] [Related]
7. Mutant 5-hydroxytryptamine 1A receptor D116A is a receptor activated solely by synthetic ligands with a rich pharmacology.
Cussac D; Palmier C; Finana F; De Vries L; Tardif S; Léger C; Bernois S; Heusler P
J Pharmacol Exp Ther; 2009 Oct; 331(1):222-33. PubMed ID: 19605522
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and pharmacological evaluation of phenoxy pyridyl derivatives as dual norepinephrine reuptake inhibitors and 5-HT1A partial agonists.
Dounay AB; Barta NS; Campbell BM; Coleman C; Collantes EM; Denny L; Dutta S; Gray DL; Hou D; Iyer R; Maiti SN; Ortwine DF; Probert A; Stratman NC; Subedi R; Whisman T; Xu W; Zoski K
Bioorg Med Chem Lett; 2010 Feb; 20(3):1114-7. PubMed ID: 20031410
[TBL] [Abstract][Full Text] [Related]
9. 2-Alkyl-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indoles as novel 5-HT6 receptor agonists.
Mattsson C; Sonesson C; Sandahl A; Greiner HE; Gassen M; Plaschke J; Leibrock J; Böttcher H
Bioorg Med Chem Lett; 2005 Oct; 15(19):4230-4. PubMed ID: 16055331
[TBL] [Abstract][Full Text] [Related]
10. 1-(2-Aminoethyl)-3-(arylsulfonyl)-1H-indoles as novel 5-HT6 receptor ligands.
Bernotas R; Lenicek S; Antane S; Zhang GM; Smith D; Coupet J; Harrison B; Schechter LE
Bioorg Med Chem Lett; 2004 Nov; 14(22):5499-502. PubMed ID: 15482912
[TBL] [Abstract][Full Text] [Related]
11. Novel 1-(azacyclyl)-3-arylsulfonyl-1H-pyrrolo[2,3-b]pyridines as 5-HT6 agonists and antagonists.
Elokdah H; Li D; McFarlane G; Bernotas RC; Robichaud AJ; Magolda RL; Zhang GM; Smith D; Schechter LE
Bioorg Med Chem; 2007 Sep; 15(18):6208-26. PubMed ID: 17624788
[TBL] [Abstract][Full Text] [Related]
12. N-Propylnoraporphin-11-O-yl carboxylic esters as potent dopamine D(2) and serotonin 5-HT(1A) receptor dual ligands.
Liu Z; Chen X; Sun P; Yu L; Zhen X; Zhang A
Bioorg Med Chem; 2008 Sep; 16(18):8335-8. PubMed ID: 18783955
[TBL] [Abstract][Full Text] [Related]
13. New piperidinyl- and 1,2,3,6-tetrahydropyridinyl-pyrimidine derivatives as selective 5-HT1A receptor agonists with highly potent anti-ischemic effects.
Kamei K; Maeda N; Katsuragi-Ogino R; Koyama M; Nakajima M; Tatsuoka T; Ohno T; Inoue T
Bioorg Med Chem Lett; 2005 Jun; 15(12):2990-3. PubMed ID: 15914001
[TBL] [Abstract][Full Text] [Related]
14. Novel inhibitors of epidermal growth factor receptor: (4-(Arylamino)-7H-pyrrolo[2,3-d]pyrimidin-6-yl)(1H-indol-2-yl)methanones and (1H-indol-2-yl)(4-(phenylamino)thieno[2,3-d]pyrimidin-6-yl)methanones.
Beckers T; Sellmer A; Eichhorn E; Pongratz H; Schächtele C; Totzke F; Kelter G; Krumbach R; Fiebig HH; Böhmer FD; Mahboobi S
Bioorg Med Chem; 2012 Jan; 20(1):125-36. PubMed ID: 22169601
[TBL] [Abstract][Full Text] [Related]
15. New insights into homopiperazine-based 5-HT1A/5-HT7R ligands: synthesis and biological evaluation.
Badarau E; Putey A; Suzenet F; Joseph B; Bojarski A; Finaru A; Guillaumet G
J Enzyme Inhib Med Chem; 2010 Jun; 25(3):301-5. PubMed ID: 19874209
[TBL] [Abstract][Full Text] [Related]
16. (2,2-Diphenyl-[1,3]oxathiolan-5-ylmethyl)-(3-phenyl-propyl)-amine: a potent and selective 5-HT(1A) receptor agonist.
Franchini S; Tait A; Prandi A; Sorbi C; Gallesi R; Buccioni M; Marucci G; De Stefani C; Cilia A; Brasili L
ChemMedChem; 2009 Feb; 4(2):196-203. PubMed ID: 19101959
[TBL] [Abstract][Full Text] [Related]
17. Syntheses and anti-cancer activities of 2-[1-(indol-3-yl-/pyrimidin-5-yl-/pyridine-2-yl-/quinolin-2-yl)-but-3-enylamino]-2-phenyl-ethanols.
Singh P; Kaur P; Luxami V; Kaur S; Kumar S
Bioorg Med Chem; 2007 Mar; 15(6):2386-95. PubMed ID: 17275313
[TBL] [Abstract][Full Text] [Related]
18. Design and synthesis of novel and potent amide linked PPARgamma/delta dual agonists.
Shi Q; Canada EJ; Xu Y; Warshawsky AM; Etgen GJ; Broderick CL; Clutinger CK; Irwin LA; Laurila ME; Montrose-Rafizadeh C; Oldham BA; Wang M; Winneroski LL; Xie C; York JS; Yumibe NP; Zink RW; Mantlo N
Bioorg Med Chem Lett; 2007 Dec; 17(24):6744-9. PubMed ID: 18029178
[TBL] [Abstract][Full Text] [Related]
19. Identification of 4-methyl-1,2,3,4,10,10a-hexahydropyrazino[1,2-a]indoles as 5-HT2C receptor agonists.
Röver S; Adams DR; Bénardeau A; Bentley JM; Bickerdike MJ; Bourson A; Cliffe IA; Coassolo P; Davidson JE; Dourish CT; Hebeisen P; Kennett GA; Knight AR; Malcolm CS; Mattei P; Misra A; Mizrahi J; Muller M; Porter RH; Richter H; Taylor S; Vickers SP
Bioorg Med Chem Lett; 2005 Aug; 15(15):3604-8. PubMed ID: 15975787
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and serotonin receptor activity of the arylpiperazine alkyl/propoxy derivatives of new azatricycloundecanes.
Bojarski AJ; Kuran B; Kossakowski J; Kozioł A; Jagiełło-Wójtowicz E; Chodkowska A
Eur J Med Chem; 2009 Jan; 44(1):152-64. PubMed ID: 18486277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
